| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Newcelx Ltd. (NCEL) has 2 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. NCEL is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 957.5K | $3.10M | +130.9K | |
| Dir | 81.8K | $265.1K | +196.4K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Samuel Olivier | Director | Buy | 81,818 | $2.75 | $224,999.50 | New | - | - | |
| Apr 27, 2026 | Revel Michel | CSO And Director | Buy | 54,545 | $2.75 | $149,998.75 | +6.0% | - | - |